Abstract
BackgroundDespite advances in checkpoint inhibitor (CPI) therapy for cancer treatment, many cancers remain resistant. Tumors deemed “cold” based on lack of T cell infiltration show reduced potential for CPI therapy....
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have